摘要
目的观察急性心肌梗死(AMI)尿激酶溶栓的疗效及安全性。方法将128例患者随机分为治疗组和对照组,在常规治疗基础上,治疗组进行尿激酶溶栓治疗,对照组给予硝酸甘油和肝素钠治疗。结果两组组间的组织型纤溶酶原激活物(t-PA)、纤溶酶原激活物抑制物(PAI-1)、血管再通率、肌酸激酶同工酶(CK-MB)的差异有显著性。结论尿激酶溶栓时间越早,再通率越高,是一种治疗AMI安全、有效的抢救措施。
Objectives Observes the AMI urokinase thrombolysis the curative effect and the security. Methods Divides into the treatment group and the control group stochastically 128 example patients, in the conventional treatment foundation, the treatment group carries on the urokinase thrombolysis treatment, the control group gives the blasting oil and the heparin sodium treatment, Results During two group of group＇s t - PA, PAI, the blood vessel pass rate, the CK - MB difference again have the significance. Conclusion The urokinase thrombolysis time more early, again passes rate is higher, is one kind treats the AMI security, the effective rescue measure.
出处
《临床和实验医学杂志》
2007年第7期40-41,共2页
Journal of Clinical and Experimental Medicine
